Q4 2020 Holdings
Filed 2021-02-04 | 24 holdings | $25.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $11.2M | 85,793 | 44.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.8M | 19,587 | 23.0% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $4.9M | 83,535 | 19.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.0M | 69,700 | 12.1% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $13.0K | 72,377 | 0.1% |
| Humana Inc(HUM) | COM | 444859102 | $12.8K | 31,162 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $12.3K | 52,000 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $11.6K | 24,851 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.5K | 230,100 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $10.6K | 70,000 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $9.1K | 182,840 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $7.8K | 78,600 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.0K | 62,060 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $6.7K | 42,929 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $5.8K | 15,700 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.1K | 13,800 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $4.2K | 32,460 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $4.1K | 72,000 | 0.0% |
| Jaws Acquisition Corp | SHS | G50744104 | $2.5K | 188,300 | 0.0% |
| Longview Acquisition Corp | COM CL A | 543195101 | $2.3K | 114,100 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $2.1K | 50,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.5K | 69,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $1.1K | 20,000 | 0.0% |
| Deerfield Healthcare Tech AC | COM CL A | 244413100 | $421 | 27,008 | 0.0% |